SCHEMBL8090115

SCHEMBL8090115

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N(CCC)CCC)ccc3OCC)nc12

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.89
PDE5A O76074 16/20 0.78
KMT2A Q03164 1/20 0.78
KDM4E B2RXH2 1/20 0.76
PDE6C P51160 3/20 0.71
PDE2A O00408 2/20 0.71
PDE9A O76083 2/20 0.71
PDE4A P27815 2/20 0.71
PDE1A P54750 2/20 0.71
PDE3B Q13370 2/20 0.71
PDE3A Q14432 2/20 0.71
PDE11A Q9HCR9 2/20 0.71
PDE10A Q9Y233 2/20 0.71
ABCC4 O15439 1/20 0.71
ABCC5 O15440 1/20 0.71
PDE6D O43924 1/20 0.71
PDE8A O60658 1/20 0.71
ABCB11 O95342 1/20 0.71
CYP3A4 P08684 1/20 0.71
HTR1A P08908 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16854873 0.94 POLB (0.80) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL7913058 0.94 POLB (1.00) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL13990518 0.94 POLB (0.92) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL7909595 0.92 POLB (0.81) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL13990475 0.91 POLB (0.82) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL13065357 0.91 POLB (0.93) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL13065925 0.90 POLB (0.81) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL13990482 0.90 POLB (0.91) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL13065922 0.90 POLB (0.86) POLBPDE5AKMT2AKDM4EPDE6C
SCHEMBL8503688 0.90 POLB (0.78) POLBPDE5AKMT2AKDM4EPDE6C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009000798-A1 SILDENAFIL N-OXIDE AS PRODRUG SOLVAY PHARMACEUTICALS B.V. (NL) 2008-12-31 WO disclosed